Be the first to like this.
6 comment(s). Last comment by TrippleZ 2022-02-19 16:56
Posted by ahbah > 2022-02-19 14:34 | Report Abuse
" Doctors and patients all knew which group the patients had been assigned to, and this kind of "open-label" trial design could have introduced bias, potentially overestimating the effect of the drug, the researchers said. "
A biased c 19 study ?
Posted by ahbah > 2022-02-19 16:33 | Report Abuse
Why publish a clinical trial that may got bias in its design ?
Posted by TrippleZ > 2022-02-19 16:50 | Report Abuse
We already made up our mind, the researchers are all bias no matter what.
Posted by ahbah > 2022-02-19 16:54 | Report Abuse
Then who will accept the conclusion drawn from such clinical trial that may got bias ?
Posted by TrippleZ > 2022-02-19 16:56 | Report Abuse
Yeah. Nobody will accept anything against Ivermectin.
No result.
3
save malaysia!
4
BFM Podcast
5
BFM Podcast
8
BFM Podcast
#
Stock
Score
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
uncensored
2,694 posts
Posted by uncensored > 2022-02-19 14:28 | Report Abuse
Ai yo yo
Ai yo yo
Ai yo yo
Old story ...loooh... no longer an interesting laaa